US regulatory status: approved. Mechanism: Unknown.
- Mechanism
- Unknown
biotech · Relapsed/Refractory Multiple Myeloma · Respiratory Distress Syndrome, Adult · INKT
MiNK Therapeutics
MiNK Therapeutics drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
NEW YORK, NY, SE HQ
2012 Founded
9 Employees
Public company Type
INKT · NYSE Ticker
Company details
- Status
- Public
- HQ
- NEW YORK, NY, SE
- Founded
- 2012
- Employees
- 9
- Programs
- 3
- Drugs
- 1
- Patents
- 6
MiNK Therapeutics pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
MiNK Therapeutics drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.